TuHURA Biosciences
HURA
90 hedge funds and large institutions have $17M invested in TuHURA Biosciences in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 9 reducing their positions, and 5 closing their positions.
520% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 5
311% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 9
248% more capital invested
Capital invested by funds: $4.88M → $17M (+$12.1M)
38% more funds holding
Funds holding: 65 → 90 (+25)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.08M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$724K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$398K |
| 4 |
State Street
Boston,
Massachusetts
|
+$274K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$187K |
| 2 |
Barclays
London,
United Kingdom
|
-$53.2K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$25.4K |
| 4 |
CWP
Cyndeo Wealth Partners
St. Petersburg,
Florida
|
-$25K |
| 5 |
HWMG
Hurlow Wealth Management Group
Bloomington,
Indiana
|
-$23.8K |
HURA Hedge Fund Activity: Q1 2026 in Review
90 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2026, worth a combined $17M — up 248% from $4.88M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new HURA positions and 5 closed out — a net gain of 26 holders — while 37 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $1.08M. The largest seller was Morgan Stanley, cutting an estimated $187K.
- 90 institutional investors held TuHURA Biosciences (HURA) as of Q1 2026, up from 65 in Q4 2025.
- Funds reported $17M of TuHURA Biosciences stock for Q1 2026, up 248% quarter-over-quarter.
- 31 funds opened new TuHURA Biosciences positions in Q1 2026 and 5 closed out, a net change of +26 holders.
- The largest TuHURA Biosciences buyer in Q1 2026 was BlackRock, an estimated $1.08M added.
- The largest TuHURA Biosciences seller in Q1 2026 was Morgan Stanley, an estimated $187K sold.
Based on aggregated 13F filings for Q1 2026.